Suchen
Drugs Made In America Acquisition Corp
DMAAZur Watchlist hinzufügen
10.650USD
+0.010+0.09%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
359.09MMarktkapitalisierung
73.88KGV TTM
mehr Informationen über Drugs Made In America Acquisition Corp Unternehmen
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp Informationen
BörsenkürzelDMAA
Name des UnternehmensDrugs Made In America Acquisition Corp
IPO-datumJan 28, 2025
CEOStockwell (Lynn)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeJan 28
Addresse1 East Broward Boulevard
StadtFT LAUDERDALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33301
Telefon19548703099
Website
BörsenkürzelDMAA
IPO-datumJan 28, 2025
CEOStockwell (Lynn)
Führungskräfte von Drugs Made In America Acquisition Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Drugs Made In America Acquisition Corp?
Die fünf größten Anteilseigner von Drugs Made In America Acquisition Corp sind: Dr. Catherine Do
Wie viele Institutionen halten Anteile an Drugs Made In America Acquisition Corp (DMAA)?
Mit Stand vom 2026Q1 halten 54 Institutionen Anteile an Drugs Made In America Acquisition Corp, mit einem Gesamtmarktwert von etwa 23.26M, was 68.99% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2073301.00 gestiegen.